ZEAL:CPH
Zealand Pharma A/S
DKKÂ 232.30
arrow_downward
-0.77%(-1.80) 1D
Nov 2, 11:10:15 AM GMT+1 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZEAL...
Open
DKKÂ 231.90
High
DKKÂ 233.70
Low
DKKÂ 231.20
Mkt. cap
16.76B
Avg. vol.
378.40K
Volume
48.06K
52-wk high
DKKÂ 556.00
52-wk low
DKKÂ 220.60
Shares outstanding
71.61M
No. of employees
578
Open
DKKÂ 231.90
High
DKKÂ 233.70
Low
DKKÂ 231.20
Mkt. cap
16.76B
Avg. vol.
378.40K
Volume
48.06K
52-wk high
DKKÂ 556.00
52-wk low
DKKÂ 220.60
Shares outstanding
71.61M
No. of employees
578
News stories
From web sources and news partners
Business Insider
·
1 minute ago
The S&P 500 may be headed for 'outsized gains' despite tech-stock rout, JPMorgan says
FXStreet
·
1 hour ago
Dow Jones futures advance as risk appetite rebounds ahead of busy week
marketscreener.com
·
13 minutes ago
Gold rebounds from one-year low as oil slides ahead of US midterms
Yahoo Finance
·
14 minutes ago
S&P 500's perfect midterm record faces a test in 2026
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees578
FoundedApr 1, 1997
Headquarters-
SectorBiotechnology
Websitezealandpharma.com